Peak Processing Limited

PKP · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.014AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.014

Open0.014

Day Range0.014 – 0.014

52-Week Range0.014 – 0.024

Volume3.00K

Market Cap21.43M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.01

Dividend Yield0.00%

Beta1.33

50-Day Avg0.0153

200-Day Avg0.0168

About

Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. The company sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Barry Katzman M.B.A.
Headquarters180 Lonsdale Street, Melbourne, VIC, Australia, 3000, Australia
Websitehttps://peakprocessing.com

Leadership

Mr. Barry Katzman M.B.A.MD, CEO & Director
Mr. Ian ScottChief Operating Officer
Ms. Amy KellyChief Administrative Officer
Mr. David SauerGeneral Counsel
Mr. Prince AdjeiSenior Vice President of Plant Operations
Mr. Adam GallagherCompany Secretary

Financials

Income Statement

Currency: AUD	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Revenue	11.07M	20.08M	25.13M	12.23M	15.56M
Growth (%)	-	+81.31%	+25.17%	-51.31%	+27.19%
Cost of Revenue	5.78M	10.78M	12.20M	5.84M	8.03M
Gross Profit	5.29M	9.29M	12.93M	6.40M	7.54M
Gross Margin	47.76%	46.29%	51.43%	52.28%	48.43%
Operating Expense	20.68M	22.06M	24.71M	31.46M	11.52M
Operating Income	-15.40M	-12.77M	-11.79M	-25.06M	-3.98M
Operating Margin	-139.04%	-63.59%	-46.91%	-204.82%	-25.59%
EBITDA	-	-9.32M	-10.44M	-28.93M	-
EBITDA Margin	-	-46.40%	-41.53%	-236.41%	-
Net Income	-15.05M	-12.12M	-13.72M	-32.06M	-8.35M
Net Income Margin	-135.88%	-60.39%	-54.62%	-262.01%	-53.64%
Interest Expense	2.00K	61.00K	1.50M	814.00K	381.00K
Interest Expense % of Total Revenue	0.02%	0.30%	5.97%	6.65%	2.45%

Balance Sheet

Currency: AUD	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Assets	53.85M	56.56M	48.34M	23.65M	20.49M
Total Liabilities	11.22M	15.12M	18.57M	23.34M	21.06M
Total Equity	42.70M	41.45M	29.77M	314.00K	-574.00K
Cash	6.39M	6.21M	3.87M	331.00K	528.00K
Net Debt	-	-	5.00K	641.00K	-

Cash Flow

Currency: AUD	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Operating Cash Flow	-	-	-6.29M	-4.39M	-8.41M
Investing Cash Flow	-	-	-1.49M	2.29M	1.08M
Financing Cash Flow	9.18M	9.89M	5.55M	-1.44M	7.42M
Capital Expenditure	2.40M	982.00K	1.49M	436.00K	941.00K
Free Cash Flow	-12.85M	-10.04M	-7.78M	-4.83M	-
FCF to OCF	-	-	123.63%	109.92%	-

Key Statistics & Ratios

Market Cap21.43M

Enterprise Value25.46M

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.71

Price / Book0.53

EPS-0.01

Book Value0.00

Revenue (TTM)12.51M

Gross Profit (TTM)618.00K

EBITDA-3.70M

Profit Margin-59.97%

Operating Margin-26.25%

Return on Equity0.00%

Return on Assets-19.05%

Shares Outstanding1.34B

Shares Float957.40M

Beta1.33

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%